Envoy Medical Reports Third Quarter 2026 Results and Highlights Continued Progress
Company Reaches Six-Month Milestone in Pivotal Trial of Fully Implanted Cochlear ImplantSecond Module of Modular PMA Application Submitted to FDA Following Quarter EndWhite Bear Lake, Minnesota--(Newsfile Corp. - November 5, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today reported financial results for the third quarter ended September 30, 2026, and provided a business...
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


